Mazur Oliwia, Bałdysz Sophia, Warowicka Alicja, Nawrot Robert
Department of Molecular Virology, Institute of Experimental Biology, Adam Mickiewicz University, Poznań, Poland.
NanoBioMedical Centre, Adam Mickiewicz University, Poznań, Poland.
Front Plant Sci. 2022 Nov 1;13:979678. doi: 10.3389/fpls.2022.979678. eCollection 2022.
Latex-bearing plants have been in the research spotlight for the past couple of decades. Since ancient times their extracts have been used in folk medicine to treat various illnesses. Currently they serve as promising candidates for cancer treatment. Up to date there have been several and studies related to the topic of cytotoxicity and anticancer activity of extracts from latex-bearing plants towards various cell types. The number of clinical studies still remains scarce, however, over the years the number is systematically increasing. To the best of our knowledge, the scientific community is still lacking in a recent review summarizing the research on the topic of cytotoxicity and anticancer activity of latex-bearing plant extracts. Therefore, the aim of this paper is to review the current knowledge on and studies, which focus on the cytotoxicity and anticancer activities of latex-bearing plants. The vast majority of the studies are , however, the interest in this topic has resulted in the substantial growth of the number of studies, leading to a promising number of plant species whose latex can potentially be tested in clinical trials. The paper is divided into sections, each of them focuses on specific latex-bearing plant family representatives and their potential anticancer activity, which in some instances is comparable to that induced by commonly used therapeutics currently available on the market. The cytotoxic effect of the plant's crude latex, its fractions or isolated compounds, is analyzed, along with a study of cell apoptosis, chromatin condensation, DNA damage, changes in gene regulation and morphology changes, which can be observed in cell post plant extract addition. The studies go beyond the molecular level by showing significant reduction of the tumor growth and volume in animal models. Additionally, we present data regarding plant-mediated biosynthesis of nanoparticles, which is regarded as a new branch in plant latex research. It is solely based on the green-synthesis approach, which presents an interesting alternative to chemical-based nanoparticle synthesis. We have analyzed the cytotoxic effect of these particles on cells. Data regarding the cytotoxicity of such particles raises their potential to be involved in the design of novel cancer therapies, which further underlines the significance of latex-bearing plants in biotechnology. Throughout the course of this review, we concluded that plant latex is a rich source of many compounds, which can be further investigated and applied in the design of anticancer pharmaceuticals. The molecules, to which this cytotoxic effect can be attributed, include alkaloids, flavonoids, tannins, terpenoids, proteases, nucleases and many novel compounds, which still remain to be characterized. They have been studied extensively in both and studies, which provide an excellent starting point for their rapid transfer to clinical studies in the near future. The comprehensive study of molecules from latex-bearing plants can result in finding a promising alternative to several pharmaceuticals on the market and help unravel the molecular mode of action of latex-based preparations.
在过去几十年里,含乳胶植物一直处于研究的聚光灯下。自古以来,它们的提取物就在民间医学中用于治疗各种疾病。目前,它们是癌症治疗的有潜力的候选物。到目前为止,已经有几项关于含乳胶植物提取物对各种细胞类型的细胞毒性和抗癌活性这一主题的研究。然而,临床研究的数量仍然很少,不过多年来这个数量在系统性地增加。据我们所知,科学界仍然缺乏一篇近期的综述来总结关于含乳胶植物提取物的细胞毒性和抗癌活性这一主题的研究。因此,本文的目的是综述当前关于细胞毒性和抗癌活性的研究,这些研究聚焦于含乳胶植物。绝大多数研究是体外研究,然而,对这个主题的兴趣导致了体内研究数量的大幅增长,产生了大量有潜力在临床试验中进行测试的含乳胶植物物种。本文分为几个部分,每个部分聚焦于特定的含乳胶植物科代表及其潜在的抗癌活性,在某些情况下,其抗癌活性与目前市场上常用治疗药物所诱导的活性相当。分析了植物粗乳胶、其馏分或分离化合物的细胞毒性作用,以及对细胞凋亡、染色质浓缩、DNA损伤、基因调控变化和形态变化的研究,这些变化可以在添加植物提取物后的细胞中观察到。体内研究通过显示动物模型中肿瘤生长和体积的显著减少,超越了分子水平。此外,我们展示了关于植物介导的纳米颗粒生物合成的数据,这被认为是植物乳胶研究中的一个新分支。它完全基于绿色合成方法,这为基于化学的纳米颗粒合成提供了一个有趣的替代方案。我们分析了这些颗粒对细胞的细胞毒性作用。关于此类颗粒细胞毒性的数据提高了它们参与新型癌症治疗设计的潜力,这进一步强调了含乳胶植物在生物技术中的重要性。在这篇综述的过程中,我们得出结论,植物乳胶是许多化合物的丰富来源,可以进一步研究并应用于抗癌药物的设计。可归因于这种细胞毒性作用的分子包括生物碱、黄酮类化合物、单宁、萜类化合物、蛋白酶、核酸酶和许多仍有待表征的新型化合物。它们在体外和体内研究中都得到了广泛研究,这为它们在不久的将来迅速转化为临床研究提供了一个很好的起点。对含乳胶植物分子的全面研究可能会找到一种有潜力替代市场上几种药物的方法,并有助于揭示基于乳胶制剂的分子作用模式。